Aminothiadiazole: an antineoplastic thiadiazole.
O'Dwyer
P J
PJ
Wagner
B H
BH
Stewart
J A
JA
Leyland-Jones
B
B
D000493:Allopurinol / Q000008:administration & dosage; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011687:Purines / Q000096:biosynthesis; D051381:Rats; D012254:Ribavirin / Q000031:analogs & derivatives / Q000627:therapeutic use; D013830:Thiadiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011687:Purines; D013830:Thiadiazoles; D012254:Ribavirin; D000493:Allopurinol; C010852:2-amino-1,3,4-thiadiazole; D007168:IMP Dehydrogenase; C033706:tiazofurin